Lifestyle Modifications Only—No Pharmacologic Treatment Indicated
At a 10-year FRAX major osteoporotic fracture risk of 12.2%, this 63-year-old woman does NOT meet the threshold for pharmacologic therapy and should focus on lifestyle interventions and fall prevention strategies.
Risk Assessment Analysis
Your patient's fracture risk falls into what guidelines classify as the "intermediate" or "moderate" risk category. The 2020 AACE/ACE guidelines clearly state that pharmacologic therapy is strongly recommended when the 10-year probability for major osteoporotic fracture is ≥20% OR hip fracture is ≥3% 1, 2. At 12.2%, she is well below the 20% threshold for major osteoporotic fracture.
The critical question here is whether her hip fracture risk reaches 3%. If it does, treatment would be indicated. However, based on the information provided showing only the major osteoporotic fracture risk of 12.2%, she appears to fall short of treatment thresholds.
What This Patient Needs Now
Immediate Actions:
- Obtain a DXA scan if not already done, as this will provide her T-score and allow for more precise risk stratification 1, 2
- Calculate her 10-year hip fracture risk specifically—if this reaches ≥3%, treatment becomes indicated 1, 2
- Assess for additional risk factors not captured in FRAX that might elevate her to high-risk status
Lifestyle Interventions (Grade A-B Evidence):
- Weight-bearing exercises
- Balance training
- Resistance exercises
- These should be performed regularly and are strongly recommended
- Home safety assessment
- Vision correction if needed
- Medication review for agents increasing fall risk
- Consider physical therapy referral for balance training
Bone-Healthy Behaviors 3:
- Calcium: 1,200 mg daily (age 51-70)
- Vitamin D: 600-800 IU daily
- Smoking cessation if applicable
- Limit alcohol to ≤2 units per day
When Treatment WOULD Be Indicated
This patient would cross into treatment territory if she has:
- T-score ≤ -2.5 at spine, femoral neck, total hip, or 1/3 radius 1, 2
- Hip fracture risk ≥3% on FRAX 1, 2
- Prior fragility fracture (even with normal BMD) 1, 2
- T-score between -1.0 and -2.5 AND major osteoporotic fracture risk ≥20% 1, 2
Follow-Up Strategy
Repeat DXA in 1-2 years 1, 2 to monitor for:
- Progression of bone loss
- Changes that might elevate her into treatment range
- Response to lifestyle interventions
Reassess FRAX annually as she ages, since fracture risk increases with age and she may cross treatment thresholds in coming years even without significant bone loss.
Common Pitfall to Avoid
Don't treat based on FRAX alone when it's in the intermediate range (10-20% for major osteoporotic fracture). The evidence strongly supports the 20% threshold for major osteoporotic fracture and 3% for hip fracture as intervention points 1, 2, 3. Treating below these thresholds exposes patients to medication risks without proven benefit in fracture reduction at this risk level.
The exception: if DXA reveals a T-score ≤ -2.5, treatment is indicated regardless of FRAX score 1, 2.